{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:14:48Z","timestamp":1760188488189},"reference-count":4,"publisher":"Elsevier BV","issue":"9028","license":[{"start":{"date-parts":[[1996,9,1]],"date-time":"1996-09-01T00:00:00Z","timestamp":841536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[1996,9]]},"DOI":"10.1016\/s0140-6736(05)65071-4","type":"journal-article","created":{"date-parts":[[2005,4,15]],"date-time":"2005-04-15T07:24:43Z","timestamp":1113549883000},"page":"632","source":"Crossref","is-referenced-by-count":12,"title":["Drug advertisements that go straight to the hippocampus"],"prefix":"10.1016","volume":"348","author":[{"given":"Sidney","family":"Wolfe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(05)65071-4_bib1","doi-asserted-by":"crossref","first-page":"912","DOI":"10.7326\/0003-4819-116-11-912","article-title":"Phamaceutical advertisements in leading medical journals: experts' assessments","volume":"116","author":"Wilkes","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0140-6736(05)65071-4_bib2","doi-asserted-by":"crossref","first-page":"950","DOI":"10.7326\/0003-4819-116-11-950","article-title":"Addressing the problem of misleading advertising","volume":"116","author":"Kessler","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0140-6736(05)65071-4_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0002-9343(82)90911-1","article-title":"Scientific versus commercial sources of influence on the prescribing behavior of physicians","volume":"73","author":"Avorn","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/S0140-6736(05)65071-4_bib4","series-title":"The effect of journal advertising on market shares of new prescriptions","article-title":"Health Care Communications","year":"1989"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673605650714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673605650714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T03:54:05Z","timestamp":1548561245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673605650714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,9]]},"references-count":4,"journal-issue":{"issue":"9028","published-print":{"date-parts":[[1996,9]]}},"alternative-id":["S0140673605650714"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(05)65071-4","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[1996,9]]}}}